This could lead to amyloid or phosphorylated tau accumulation in the brain parenchyma, which are thought to be important elements in the etiology of AD, and whose concentration in the CSF was shown to predict clinical development (Wolfsgruber et al., 2017). Here, MAPT is linked to Alzheimer disease.